Manchand P S, Cerruti R L, Martin J A, Hill C H, Merrett J H, Keech E, Belshe R B, Connell E V, Sim I S
Department of Chemistry Research, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
J Med Chem. 1990 Jul;33(7):1992-5. doi: 10.1021/jm00169a029.
The hydroxy metabolites of rimantadine (3-5) were synthesized and compared to amantadine (1) and rimantadine (2) for their ability to inhibit the replication of influenza viruses in vitro. All three metabolites were inhibitory to wild-type influenza A viruses (H3N2 and H1N1). In particular, 2-hydroxyrimantadine (3) showed similar activity to amantadine, but the 3- and 4-hydroxy metabolites (4 and 5, respectively), both of which are found in rimantadine-treated patients, showed only modest inhibitory activity. A rimantadine-resistant isolate of influenza A virus exhibited cross-resistance to amantadine and to each of the metabolites 3-5. None of the compounds were effective against influenza B virus.
金刚乙胺的羟基代谢产物(3 - 5)被合成出来,并与金刚烷胺(1)和金刚乙胺(2)在体外抑制流感病毒复制的能力方面进行了比较。所有这三种代谢产物对野生型甲型流感病毒(H3N2和H1N1)均有抑制作用。特别是,2 - 羟基金刚乙胺(3)表现出与金刚烷胺相似的活性,但在接受金刚乙胺治疗的患者体内均能发现的3 - 和4 - 羟基代谢产物(分别为4和5)仅表现出适度的抑制活性。一株对金刚乙胺耐药的甲型流感病毒分离株对金刚烷胺以及代谢产物3 - 5均表现出交叉耐药性。这些化合物对乙型流感病毒均无作用。